Scholars Central

Conference abstractPublished 22 Jun 2023

Butyrate paradox

Authors: Alina Makarova

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Butyrate reduces colorectal cancer development risk, being transported into epithelial cells of the colon via monocarboxylate transporter 1 (MCT1) and sodium-coupled monocarboxylate transporter 1 (SMCT1). Experimentally, tumor cells of the colon epithelium show a decrease in butyrate adsorption, probably due to MCT1 and SMCT1 proteins expression decrease. To study butyrate level in copro filtrate samples of patients with colorectal cancer. Materials and methods: 21 patients with newly diagnosed colorectal cancer were examined: 10 males with a median age of 71 (61-73) years old and 11 females with a median age of 64 (63-74) years old. The concentration of short-chain fatty acids (SCFA, C2-C6) in copro filtrate samples of all patients was studied using gas-liquid chromatography. Results: Patients showed the SCFA total level decrease – 5.2 (4.2-6.8) mg/g, suggesting the metabolic activity decrease in the colon microflora, but also butyrate concentration variability, with median value of 0.953 (0.518-4.275) mg/g and its share of 18 (13-22)%. The studied group showed 47.6% of decrease cases in butyrate level, 23.8% had an increase, 28.6% showed normal values. Conclusions: Studies have shown that butyrate has tumor suppression properties, which is probably due to its effect as a histone deacetylase inhibitor. It also promotes carcinogenesis in various models of colorectal cancer. This discrepancy in the effect of butyrate on the neoplastic process is called the “Butyrate paradox” (PedroGonçalves et al, 2016) and is possibly related to the concentration of butyrate. A deeper understanding of microbial metabolites’ action may open up new possibilities for non-invasive biomarkers search. Recent publications 1. Makarova A.A., Diukova G.M., Ruchkina I.N., Romashkina N.V., Indejkina L.K., Degterev D.A.,Dbar S.R., Parfenov A.I. Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome // Terapevticheskii arkhiv. - 2022. - Vol. 94. - N. 2S. - P. 356- 361. doi: 10.26442/00403660.2022.02.201394 2. L.Кh. Indeykina, Е.А. Sabelnikova, G.G. Varvanina, S.U. Silvestrova1, А.V. Smirnova, L.М. Krums1, A.A. Viaznikova (A.A. Makarova), А.I. Parfenov. The role of fibroblast growth factor 19 in pathogenesis of hologenic diarrhea of the patients who underwent cholecystectomy. Terapevticheskii Arkhiv (Ter. Arkh.). 2021; 93 (2): 174–178. DOI: 10.26442/00403660.2021.02.200621 3. Indeykina Lilia, Sabelnikova Elena, Varvanina Galina, Silvestrova Svetlana,Smirnova Аnna, Krums Larisa, Viaznikova Alina (Makarova Alina), Dbar Saria, Parfenov Аsvold The impact of regulatory molecules of hepato-biliary synthesis of bile acids on developing diarrhoea after cholecystectomy. Latvijas Universitātes 79. starptautiskā zinātniskā konference “Starpdisciplinārie pētījumi medicīnas koledžās”. Tēžu krājums. Rīga: Latvijas Universitāte, 2021. 55 lpp. ISBN 978-9934-18-668-4 (PDF) https://doi.org/10.22364/luszk.79.spmk.tk

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Hepato-Gastroenterology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hepato-Gastroenterology
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Alina Makarova”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels